Literature DB >> 12537102

Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.

Miguel Angel Basombrío1, María Asunción Segura, Julio R Nasser.   

Abstract

Trypanosoma cruzi infections persist for the lifetime of humans and laboratory animals as either latent or pathogenic parasitism. Mice inoculated with a nonpathogenic, attenuated strain (TCC) display resistance against virulent challenge, with a strong control of parasitemia and protection against tissue lesions for more than 12 mo. Three main approaches were used to test whether protection by TCC inocula is based on a latent infection or on a "sterile" immunological memory: curative Benznidazole (Bzl) treatment, serological reactions, and detection of infection by polymerase chain reaction (PCR). If resistance is maintained in the absence of infection, it should not be reduced by Bzl treatment and TCC-inoculated animals should not maintain long-term serological or PCR reactivity. The Bzl treatment after TCC inoculations did not reduce, after periods of up to 420 days, TCC-induced resistance to challenge. But TCC inocula given during Bzl treatment conferred short-term, but not long-term. protection. Maintenance of high antibody levels and protection were better in the virulent Tulahuen (TUL) strain than in the attenuated TCC strain infections, and trypomastigote inocula of either strain were better inducers of antibodies and resistance than epimastigotes. PCR detection of T. cruzi DNA was positive in almost all TUL strain-inoculated animals and negative in immunocompetent animals inoculated with TCC epimastigotes, although high numbers of TCC trypomastigotes produced persistent PCR signals of infection in newborn BALB mice. Thus, 2 polar models were developed, where latent infection by TCC was either demonstrated or excluded. In both, resistance to virulent challenge was maintained during long periods. But late declination of antibody titers (>200 days) and resistance to challenge (>350 days) was observed in animals displaying clearance of all signals of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537102     DOI: 10.1645/0022-3395(2002)088[1107:RBLTRT]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  5 in total

1.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.

Authors:  Sue-Jie Koo; Imran H Chowdhury; Bartosz Szczesny; Xianxiu Wan; Nisha J Garg
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Authors:  Vandanajay Bhatia; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

3.  Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi.

Authors:  M Paola Zago; Alejandra B Barrio; Rubén M Cardozo; Tomás Duffy; Alejandro G Schijman; Miguel A Basombrío
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

4.  Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.

Authors:  Cecilia Perez Brandan; Angel M Padilla; Dan Xu; Rick L Tarleton; Miguel A Basombrio
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

5.  A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

Authors:  Fernando J Sánchez-Valdéz; Cecilia Pérez Brandán; Galia Ramírez; Alejandro D Uncos; M Paola Zago; Rubén O Cimino; Rubén M Cardozo; Jorge D Marco; Arturo Ferreira; Miguel Ángel Basombrío
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.